Private Wealth Asset Management’s Royalty Pharma RPRX Stock Holding History

Private Wealth Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.8K	Hold	906	–	–	﹤0.01%	430
2026 Q1	$43.5K	Sell	906 -6	-0.7%	-$263	﹤0.01%	451
2025 Q4	$35.2K	Hold	912	–	–	﹤0.01%	467
2025 Q3	$32.2K	Hold	912	–	–	﹤0.01%	459
2025 Q2	$32.9K	Sell	912 -36	-4%	-$1.19K	﹤0.01%	461
2025 Q1	$29.5K	Buy	+948	New	+$30K	﹤0.01%	448

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Wealth Asset Management's RPRX Position: Q2 2026 in Review

Private Wealth Asset Management held its Royalty Pharma (RPRX) position steady in Q2 2026 at 906 shares worth $50.8K. The position accounts for ﹤0.01% of the portfolio, ranked #430.

Private Wealth Asset Management first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Private Wealth Asset Management held 906 shares of Royalty Pharma worth $50.8K as of Q2 2026.
Private Wealth Asset Management left its Royalty Pharma share count unchanged in Q2 2026.
Royalty Pharma made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q2 2026, its #430 holding.
Private Wealth Asset Management first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.